2013年-2021年我国急性白血病住院费用分析

Analysis on the Hospitalization Expenses for Acute Leukemia in China from 2013 to 2021

目的探讨急性白血病的住院费用构成与住院费用变化趋势,为有效控制医疗费用不合理增长提供研究基础。方法收集统计年鉴中2013年-2021年急性白血病住院费用相关信息,运用Excel展示费用变动情况并计算年均增长率,采用灰色关联分析对2013年-2021年我国急性白血病住院费用关联度进行分析,采用结构变动度分析费用构成的总体特征和费用内部结构的动态变化趋势,找出影响医疗费用变动的主要因素。结果2013年-2021年急性白血病次均医药费逐年增长,年均增速高达8.45%;灰色关联分析显示:住院费用中关联最大的为药费(1.00),其次为治疗费(0.72)、检查费(0.72)、卫生材料费(0.71)和手术费(0.69);结构变动度分析显示:2013年-2021年急性白血病患者住院费用的总结构变动度为13.25%,2016年-2017年变化幅度最大,住院费用变动最大的医疗费用为药费,住院费用结构变动贡献率最大的也是药费。高额的药品费用是住院费用增加的主要影响因素。结论急性白血病住院费用逐年增长,药费是住院费用增长的主要因素,其次是治疗费和检查费。建议建立科学控费评价指标体系,不断优化临床路径,规范诊疗行为,合理降低药费,多措并举减轻急性白血病患者经济负担。

Objectives To explore the composition and trend of hospitalization expenses in acute leukemia,and provide a research basis for effectively controlling the unreasonable growth of medical expenses.Methods To collect relevant information on hospitalization expenses for acute leukemia from 2013 to 2021 in the statistical yearbook,use Excel to display the changes in expenses and calculate the annual growth rate.Use grey correlation analysis to analyze the correlation degree of hospitalization expenses for acute leukemia in China from 2013 to 2021.Use structural change analysis to analyze the overall characteristics of expense composition and the dynamic trend of internal structure of expenses,and identify the main factors affecting the changes in medical expenses.Results From 2013 to 2021,the average medical expenses for acute leukemia increased year by year,with an average annual growth rate of 8.45%;Grey correlation analysis showed that the highest correlation among hospitalization expenses was drug expenses(1.00),followed by treatment expenses(0.72),examination expenses(0.72),sanitary material expenses(0.71),and surgical expenses(0.69).The analysis of structural change showed that the summary structural change of hospitalization expenses for acute leukemia patients from 2013 to 2021 was 13.25%,with the largest change from 2016 to 2017.The medical expenses with the largest change in hospitalization expenses were drug expenses,and the contribution rate of structural change in hospitalization expenses was also drug expenses.The high cost of drugs was the main influencing factor for the increase in hospitalization expenses.Conclusions The inpatient expenses of acute leukemia increased year by year,and the drug expense was the main factor,followed by the treatment expense and the examination expense.It was suggested to establish a scientific evaluation index system for expense control,continuously optimize clinical pathways,standardize diagnosis and treatment behaviors,rationally reduce drug expense,and take multiple measures to reduce the economic burden of acute leukemia patients.